Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qufeng Gutong gel paste for chronic musculoskeletal pain due to knee osteoarthritis
ChiCTR2400081266Phase 4Recruiting
- Sponsor
- 中国中医科学院望京医院
- Start
- Feb 2024
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Qufeng Gutong gel paste in knee osteoarthritis (OA) (2 cohorts), sponsored by 中国中医科学院望京医院. Primary endpoint: Visual analogue scale pain score for knee osteoarthritis. Started Feb 2024; status: recruiting.
02
Drugs
Qufeng Gutong gel paste
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2400081266.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400081266.